- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Accelerate Product Innovation & Availability
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
Status
Ongoing
Phase
IIb
Principal Investigator(s)
Lawrence Corey, Myron Cohen
Objective
This study will evaluate the safety and efficacy of the human monoclonal antibody (mAb) VRC-HIVMAB060-00-AB (VRC01) in preventing HIV-1 infection in high-risk, HIV-uninfected women.
The study also looks at the safety of these antibody infusions and it looks over time at how much antibody is in the blood of study participants receiving different amounts or doses of the antibody
Prevention Option(s)
Antibody Related Research
Study Design
Randomized
Double-blind
Arms and Assigned Interventions
Description
Participants will receive an intravenous (IV) infusion of 10 mg/kg of VRC01 over about 30 to 60 minutes at Weeks 0, 8, 16, 24, 32, 40, 48, 56, 64, and 72.
Products
VRC01
ARMs
Experimental
Description
Participants will receive an IV infusion of 30 mg/kg of VRC01 over about 30 to 60 minutes at Weeks 0, 8, 16, 24, 32, 40, 48, 56, 64, and 72.
Products
VRC01
ARMs
Experimental
Description
Participants will receive an IV infusion of placebo for VRC01 over about 30 to 60 minutes at Weeks 0, 8, 16, 24, 32, 40, 48, 56, 64, and 72.
ARMs
Placebo Comparator
Official Code
Related Publications
Similar Trials
Trial Sponsors
NIAID
April 2016
September 2020
Enrollment
1 900
18
Years
50
Years
Population
Women
Sites
Groote Schuur HIV CRS
Cape Town
South Africa
Soweto HVTN CRS
Johannesburg
South Africa
eThekwini CRS
Durban, KwaZulu-Natal
South Africa
CAPRISA Vulindlela Clinical Research Site
Pietermaritzburg, KwaZulu-Natal
South Africa
Gaborone CRS
Gaborone
Botswana
Kisumu CRS
Kenya
Blantyre CRS
Malawi
Malawi CRS
Malawi
Centro de Investigação e Treino em Saúde de Polana Caniço
Maputo
Mozambique
Chatsworth CRS
Chatsworth, KwaZulu-Natal
South Africa
Wits HIV CRS
Johannesburg, Gauteng
South Africa
Mbeya Med. Research Program, Mbeya Referral Hospital CRS
Mbeya
United Republic of Tanzania
Seke South Clinical Research Site
Harare
Zimbabwe
UZ-Parirenyatwa
Harare
Zimbabwe
Spilhaus Clinical Research Site
Harare
Zimbabwe